Abstract 931: From bench to bedside: Using ProTide chemistry to transform 3'-deoxyadenosine into the novel anti-cancer agent Nuc-7738
Hagen Schwenzer(University of Oxford), Sarah P. Blagden(Churchill Hospital), Sebastian Nijman(Austrian Academy of Sciences), Mustafa Elshani(University of St Andrews), Gareth L. Bond(Ludwig Cancer Research), Mary Kudsy(University of St Andrews), Ruud van Stiphout(Nuffield Orthopaedic Centre), Erica De Zan(Nuffield Orthopaedic Centre), Josephine Morris(University of Oxford), Valentina Ferrari(Cardiff University), Michaela Serpi(Cardiff University), James Chettle(University of Oxford), David G. Harrison(Emory University)
Cited by 1
Related Papers
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
|Journal of Clinical Investigation|1996|2.4k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
|Circulation Research|2001|1.2k
Cellular and molecular mechanisms of endothelial cell dysfunction.
|Journal of Clinical Investigation|1997|1.1k